We would like to pass on the following notification to our clients about the current Heartworm treatment protocol:
The manufacturer of Immiticide, the current product used for the treatment of in-stage heartworm infected dogs, has recently released a letter to our office that the current manufacturing facility of Immiticide is no longer going to remain open. Due to this, the product will be in short-supply and delegated to those canines that warrant immediate treatment.
The manufacturer of Immiticide is trying to locate an alternative manufacturing facility and will keep us informed.
Please remember to keep your pet current on their heartworm testing (recommended yearly in our area by the American Heartworm Society) and please keep your pet on preventative once a month.
Heartworm disease can have serious health complications including scarring of lung and heart tissue and, in some cases, may cause death.